Bioventus Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-282025-12-312025-09-272025-06-282025-03-292024-12-312024-09-282024-06-29
Total Revenue132.1M157.9M138.7M147.7M123.9M153.6M139.0M151.2M
Cost of Goods Sold42.4M50.4M45.8M47.0M42.4M51.0M45.4M47.6M
Gross Profit89.7M107.5M92.8M100.7M81.5M102.7M93.6M103.6M
R&D Expenses2.5M3.0M2.9M3.2M3.0M3.2M3.8M4.2M
Operating Expenses80.8M85.8M80.7M82.0M76.5M94.7M89.5M135.1M
Operating Income8.9M21.7M12.1M18.6M5.0M8.0M4.1M-31.5M
Other Income / Gains-4.4M-7.6M-7.4M-8.3M-8.4M-7.8M-8.9M-10.1M
Net Income3.1M14.8M3.2M7.5M-2.6M-156K-4.8M-25.7M
EPS (Diluted)0.0460.220.0470.11-0.04-0.002-0.07-0.37
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.6790.6810.670.6820.6580.6680.6730.685
General And Administrative Expenses00000000
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses78.3M82.8M77.8M78.9M73.5M86.6M81.1M96.7M
Other Expenses000004.8M4.6M34.2M
Cost And Expenses123.2M136.2M126.5M129.0M118.9M145.7M134.9M182.7M
Interest Income00000000
Interest Expense4.3M5.3M6.2M7.5M7.5M9.0M9.5M9.9M
Depreciation And Amortization11.2M11.7M11.4M12.0M11.9M12.4M12.3M13.1M
Ebitda20.0M31.1M22.3M29.9M16.0M21.6M17.0M-18.5M
Ebitdaratio0.1520.1970.160.2020.1290.1410.122-0.123
Operating Income Ratio0.0670.1380.0870.1260.040.0520.029-0.208
Income Before Tax4.5M14.1M4.7M10.3M-3.4M232K-4.8M-41.6M
Income Before Tax Ratio0.0340.090.0340.07-0.0280.002-0.035-0.275
Income Tax Expense571K-3.2M664K1.0M-95K550K589K-7.3M
Net Income Ratio0.0240.0930.0230.051-0.021-0.001-0.035-0.17
Epsdiluted0.0450.210.0460.11-0.04-0.002-0.07-0.37
Weighted Average Shs Out67.3M66.6M66.9M66.5M66.0M65.5M65.3M64.1M
Weighted Average Shs Out Dil70.0M68.9M68.8M68.5M66.0M65.5M65.3M64.1M